A nomogram incorporating radiomics and dosiomics features, along with clinical factors, was developed to predict overall survival in esophageal squamous cell carcinoma (ESCC) patients undergoing definitive chemoradiotherapy. Dosiomics features outperformed radiomics features in predicting survival outcomes. The combined model exhibited significant differences in overall survival between high- and low-risk groups, highlighting its potential for personalized treatment strategies in ESCC patients.
Journal Article by Kawahara D, Nishioka R (…) Sasaki R et 3 al. in Eur J Surg Oncol
Copyright © 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.